The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Pharmacy and Science

• Publication date

  2002-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/JPS.10182PMID 12115809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The absorption and transport of dietary cholesterol in the presence of peanut oil or randomized peanut oil

  2006cited by this paper
• Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients

  2004cited by this paper
• Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation.

  2001cited by this paper
• The Stereoselective Distribution of Halofantrine Enantiomers Within Human, Dog, and Rat Plasma Lipoproteins

  2000cited by this paper
• Determination of the free fraction and relative free fraction of drugs strongly bound to plasma proteins.

  2000cited by this paper
• Mechanism of cardiotoxicity of halofantrine

  2000cited by this paper
• Stereoselective pharmacokinetics of desbutylhalofantrine, a metabolite of halofantrine, in the rat after administration of the racemic metabolite or parent drug

  2000cited by this paper
• Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisons

  1999cited by this paper
• Effects of Hyperlipidemia on the Pharmacokinetics of Nifedipine in the Rat

  1999cited by this paper
• Effects of hyperlipidemia on the pharmacokinetics of nifedipine in the rat.

  1999cited by this paper
• Differences in the lipoprotein binding profile of halofantrine in fed and fasted human or beagle plasma are dictated by the respective masses of core apolar lipoprotein lipid.

  1999cited by this paper
• Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.

  1999cited by this paper
• Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state.

  1998cited by this paper
• Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans

  1997cited by this paper
• A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine.

  1996cited by this paper
• The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum.

  1995cited by this paper
• Stereochemical Aspects of Pharmacotherapy

  1995cited by this paper
• Effect of long term feeding of rice bran oil upon lipids and lipoproteins in rats

  1995cited by this paper
• A liquid chromatographic assay for the stereospecific quantitative analysis of halofantrine in human plasma.

  1995cited by this paper
• Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat.

  1993cited by this paper
• Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats.

  1992cited by this paper
• Lipid metabolism responses in rats fed beef tallow, native or randomized fish oil and native or randomized peanut oil.

  1991cited by this paper
• Pharmacokinetics of halofantrine in man: effects of food and dose size.

  1989cited by this paper
• Cholesterol determination in serum after fractionation of lipoproteins by immunoprecipitation.

  1985cited by this paper
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper
• Quantitative determination of serum triglycerides by the use of enzymes.

  1973cited by this paper

• Hyperlipidemia: Insights into Mechanisms Involved in Modulation of Drug Pharmacokinetics and Response

  2020cites this paper
• Bioavailability Enhancement and Food Effect Elimination of Abiraterone Acetate by Encapsulation in Surfactant-Enriched Oil Marbles

  2020cites this paper
• Mechanistic Oral Absorption Modeling of Halofantrine: Exploring the Role of Intestinal Lymphatic Transport.

  2020cites this paper
• In Silico Docking of Alkylphosphocholine Analogs to Human Serum AlbuminPredict Partitioning and Pharmacokinetics.

  2019cites this paper
• Pharmacokinetic alterations in poloxamer 407-induced hyperlipidemic rats

  2019influential citation
• Oleic acid increases uptake and decreases the P-gp-mediated efflux of the veterinary anthelmintic Ivermectin

  2018cites this paper
• Antiprotozoal and Anthelmintic Agents

  2018cites this paper
• Pharmacokinetics of metformin in the rat: assessment of the effect of hyperlipidemia and evidence for its metabolism to guanylurea.

  2017cites this paper
• THE IMPACT OF OBESITY ON PROTEINS INVOLVED IN DRUG METABOLISM

  2017cites this paper
• The pharmacokinetics of dronedarone in normolipidemic and hyperlipidemic rats

  2016influential citation
• Lipid-Based Formulations for Oral Drug Delivery: Effects on Drug Absorption and Metabolism.

  2015cites this paper
• Strategies to Address Low Drug Solubility in Discovery and Development

  2013cites this paper
• Effect of rat serum lipoproteins on mRNA levels and amiodarone metabolism by cultured primary rat hepatocytes.

  2013cites this paper
• The impact of lymphatic transport on the systemic disposition of lipophilic drugs.

  2013cites this paper
• Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studies.

  2012cites this paper
• Effect of serum lipoproteins on stereoselective halofantrine metabolism by rat hepatocytes.

  2012cites this paper
• An examination of the potential effect of lipids on the first-pass metabolism of the lipophilic drug anethol trithione.

  2011cites this paper
• Pharmacokinetic Behaviors of Orally Administered Drugs

  2011cites this paper
• Pharmacokinetics of PSC 833 (valspodar) in its Cremophor EL formulation in rat

  2010cites this paper
• Effect of experimental hyperlipidaemia on the electrocardiographic effects of repeated doses of halofantrine in rats

  2010influential citation
• Effect of hypertriglyceridemia on the pharmacokinetics and blood-brain barrier penetration of clozapine and norclozapine following administration to rats.

  2010cites this paper
• Determination of halofantrine and its main metabolite desbutylhalofantrine in rat plasma by high-performance liquid chromatography with on-line UV irradiation and peroxyoxalate chemiluminescence detection.

  2009cites this paper
• The effect of experimental hyperlipidemia on the stereoselective tissue distribution, lipoprotein association and microsomal metabolism of (+/-)-halofantrine.

  2009cites this paper
• Effect of bile and lipids on the stereoselective metabolism of halofantrine by rat everted-intestinal sacs.

  2009cites this paper
• Experimental Hyperlipidemia Causes an Increase in the Electrocardiographic Changes Associated With Amiodarone

  2009cites this paper
• Clinical pharmacokinetics and pharmacodynamics of antimalarial combination therapy

  2009cites this paper
• The role of molecular physicochemical properties and apolipoproteins in association of drugs with triglyceride‐rich lipoproteins: in‐silico prediction of uptake by chylomicrons

  2009cites this paper
• The effect of oral lipids and circulating lipoproteins on the metabolism of drugs

  2009influential citation
• Modifications in low-density lipoprotein receptor expression affects Cyclosporin A cellular uptake and cytotoxicity.

  2008cites this paper
• Effects of intestinal constituents and lipids on intestinal formation and pharmacokinetics of desethylamiodarone formed from amiodarone

  2008cites this paper
• Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

  2008cites this paper
• Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery

  2008cites this paper
• The stereoselective metabolism of halofantrine to desbutylhalofantrine in the rat: evidence of tissue-specific enantioselectivity in microsomal metabolism.

  2007cites this paper
• Effect of a high-fat meal on absorption and disposition of lipophilic compounds: the importance of degree of association with triglyceride-rich lipoproteins.

  2007cites this paper
• Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices.

  2007cites this paper
• The effect of a high-fat meal on the pharmacodynamics of a model lipophilic compound that binds extensively to triglyceride-rich lipoproteins.

  2007cites this paper
• The Influence of Hyperlipoproteinemia on in Vitro Distribution of Amiodarone and Desethylamiodarone in Human and Rat Plasma

  2007cites this paper
• A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.

  2007cites this paper
• The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat

  2006cites this paper
• A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics

  2006cites this paper
• UNIVERSIDADE FEDERAL DE OURO PRETO NÚCLEO DE PESQUISA EM CIÊNCIAS BIOLÓGICAS PROGAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS NANOCÁPSULAS DE POLI--CAPROLACTONA CONTENDO HALOFANTRINO: DESENVOLVIMENTO, CARACTERIZAÇÃO E ESTUDO DA CARDIOTOXICIDADE.

  2006cites this paper
• Phytopreventative anti-hyperlipidemic effects of gynostemma pentaphyllum in rats.

  2005cites this paper
• Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat‐meal rat models

  2005influential citation
• Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake.

  2004cites this paper
• High-throughput determination of the free fraction of drugs strongly bound to plasma proteins.

  2004cites this paper
• Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model

  2004cites this paper
• Stereoselectivity in the Pharmacodynamics and Pharmacokinetics of the Chiral Antimalarial Drugs

  2003cites this paper
• Does stereoselective lymphatic absorption contribute to the enantioselective pharmacokinetics of halofantrine In Vivo?

  2003cites this paper